http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05279344-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
filingDate 1993-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05279344-A
titleOfInvention N-5-protected 2,5-diamino-4,6-dichloropyrimidine and process for producing the same
abstract (57) [Summary] (Modified) [Purpose] N-5-protected 2,5-diamino-of formula I Provided is an improved process for making 4,6-dichloropyrimidine. The N-protected aminomalonic acid ester of formula II is cyclized with guanidine in the presence of an alkali alcoholate to an N-5-protected 4,6-dihydroxy-2,5-diaminopyrimidine of formula III, which is obtained A compound of formula I by chlorination of the compound with phosphorus oxychloride, And compounds of formula I. [Wherein R is an alkoxy group or CF 3 and R 1 is C Meaning 1 to 4 lower alkyl groups] [Effect] The compound of formula I is an intermediate for producing a drug having antiviral properties.
priorityDate 1992-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19094597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234277612

Total number of triples: 16.